Arcturus Therapeutics Holdings Inc.
ARCT
$10.53
$0.232.23%
NASDAQ
| 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
|---|---|---|---|---|---|
| Net Income | -172.30% | -163.07% | -189.63% | -196.43% | -417.95% |
| Total Depreciation and Amortization | 19.85% | 31.45% | 51.34% | 74.53% | 93.65% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 2,885.95% | 7,005.39% | 1,694.28% | 8,558.29% | -96.18% |
| Change in Net Operating Assets | -381.93% | -195.47% | -179.40% | 216.48% | 158.78% |
| Cash from Operations | -230.11% | -142.08% | -151.76% | -72.95% | -156.57% |
| Capital Expenditure | 77.66% | 73.89% | 65.56% | 61.15% | 62.45% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | 77.66% | 73.89% | 65.56% | 61.15% | 62.45% |
| Total Debt Issued | -- | -100.00% | -- | -- | -- |
| Total Debt Repaid | -- | 34.13% | 38.20% | 38.20% | -847.28% |
| Issuance of Common Stock | 65.33% | 145.26% | 373.45% | 202.77% | 53.06% |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | 122.49% | -74.54% | 125.30% | 117.88% | -742.50% |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -21.94% | -158.00% | -166.70% | 83.58% | -310.61% |